​

Oculis (OCS) Stock Forecast, Price Target & Predictions

OverviewOwnershipChart

OCS Stock Forecast

Oculis (OCS) stock forecast, based on 9 Wall Street analysts, predicts a 12-month average price target of $36.75, with a high of $45.00 and a low of $26.00. This represents a 354.26% increase from the last price of $8.09.

$5 $13 $21 $29 $37 $45 High: $45 Avg: $36.75 Low: $26 Last Closed Price: $8.09

OCS Stock Rating

Oculis stock's rating consensus is Buy, based on 9 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 9 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 9 0 9 Strong Sell Sell Hold Buy Strong Buy

OCS Price Target Upside V Benchmarks

TypeNameUpside
StockOculis354.26%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts--8
Avg Price Target--$44.88
Last Closing Price$8.09$8.09$8.09
Upside/Downside--454.76%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 2637---10
Sep, 2637---10
Aug, 2637---10
Jul, 2638---11
Jun, 2638---11
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jun 01, 2026Robert W. Baird$38.00$14.51161.89%369.72%
Jun 01, 2026Guggenheim$45.00$22.7198.15%456.24%
Jun 01, 2026Needham$38.00$22.7167.33%369.72%
Jun 01, 2026H.C. Wainwright$26.00$22.7114.49%221.38%
May 20, 2026Guggenheim$75.00$27.91168.72%827.07%
May 12, 2026H.C. Wainwright$47.00$30.3055.12%480.96%
Mar 04, 2026Annabel SamimyStifel Nicolaus$50.00$27.7280.38%518.05%
Dec 19, 2025Annabel SamimyStifel Nicolaus$40.00$20.9890.66%394.44%
Oct 08, 2025Chardan Capital$51.00$19.06167.58%530.41%
Oct 07, 2025Yi ChenH.C. Wainwright$36.00$18.5693.97%344.99%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 21, 2026H.C. WainwrightBuyBuyhold
Sep 18, 2026H.C. WainwrightBuyBuyhold
Aug 25, 2026H.C. WainwrightBuyBuyhold
Jun 11, 2026H.C. WainwrightBuyBuyhold
Jun 01, 2026NeedhamBuyBuyhold
May 20, 2026GuggenheimBuyinitialise
May 12, 2026H.C. WainwrightBuyBuyhold
Oct 07, 2025H.C. WainwrightBuyBuyhold
Aug 27, 2025NeedhamBuyinitialise
Aug 22, 2025H.C. WainwrightBuyBuyhold

Financial Forecast

EPS Forecast

$-5 $-4 $-3 $-2 $-1 $0 $1 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.97-----
Avg Forecast$-3.07$-1.86$-1.86$-2.37$-1.77$-0.91
High Forecast$-1.68$-1.61$-1.20$0.22$0.11$0.17
Low Forecast$-4.07$-1.96$-2.47$-4.50$-3.06$-4.35
Surprise %-3.26%-----

Revenue Forecast

$0 $170M $340M $510M $680M $850M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$883.00K-----
Avg Forecast$901.80K$903.13K$6.99M$15.38M$85.45M$211.74M
High Forecast$998.11K$930.22K$26.20M$60.26M$334.90M$829.87M
Low Forecast$787.98K$803.78K$568.78K$1.31M$7.27M$18.02M
Surprise %-2.09%-----

Net Income Forecast

$-150M $-110M $-70M $-30M $10M $50M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-88.80M-----
Avg Forecast$-75.96M$-58.52M$-65.28M$-76.01M$-44.10M$-27.13M
High Forecast$-50.15M$-48.19M$-35.90M$6.52M$3.39M$5.14M
Low Forecast$-121.55M$-58.57M$-73.97M$-134.57M$-91.59M$-130.08M
Surprise %16.90%-----

OCS Forecast FAQ

Is Oculis stock a buy?

Oculis stock has a consensus rating of Buy, based on 9 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 9 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Oculis is a favorable investment for most analysts.

What is Oculis's price target?

Oculis's price target, set by 9 Wall Street analysts, averages $36.75 over the next 12 months. The price target range spans from $26 at the low end to $45 at the high end, suggesting a potential 354.26% change from the previous closing price of $8.09.

How does Oculis stock forecast compare to its benchmarks?

Oculis's stock forecast shows a 354.26% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Oculis over the past three months?

  • October 2026: 30.00% Strong Buy, 70.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • September 2026: 30.00% Strong Buy, 70.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • August 2026: 30.00% Strong Buy, 70.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Oculis’s EPS forecast?

Oculis's average annual EPS forecast for its fiscal year ending in December 2024 is $-1.86, marking a -37.37% decrease from the reported $-2.97 in 2023. Estimates for the following years are $-1.86 in 2025, $-2.37 in 2026, $-1.77 in 2027, and $-0.91 in 2028.

What is Oculis’s revenue forecast?

Oculis's average annual revenue forecast for its fiscal year ending in December 2024 is $903.13K, reflecting a 2.28% increase from the reported $883K in 2023. The forecast for 2025 is $6.99M, followed by $15.38M for 2026, $85.45M for 2027, and $211.74M for 2028.

What is Oculis’s net income forecast?

Oculis's net income forecast for the fiscal year ending in December 2024 stands at $-58.516M, representing a -34.10% decrease from the reported $-88.802M in 2023. Projections indicate $-65.281M in 2025, $-76.007M in 2026, $-44.104M in 2027, and $-27.129M in 2028.